Sep 10, 2010
Today, the Midwest Cancer Alliance (MCA) announced that many more people will have access to clinical trials in the next year.
Clinical trials are the best way to learn whether new treatments work and how better to use drugs that are currently on the market – yet only 3 percent of cancer patients who are eligible to enroll in a clinical trial actually do so. Bringing clinical trials to cancer patients as close to home as possible is one of the crucial missions of the Midwest Cancer Alliance.
Headquartered at the University of Kansas Medical Center, the Midwest Cancer Alliance is a network of professionals working to advance the quality and reach of cancer prevention, early detection, care and survivorship programs in
Since it was launched in 2008:
n More than 11,450 people have attended community education and screening events supported by MCA, members, and partners.
n 6,200 cancer screenings resulted in more than 470 referrals back to local physicians for follow-up on abnormal results.
n Cancer patients are actively screened for clinical trial eligibility at four MCA sites.
At its annual meeting today on the University of Kansas Medical Center campus, the MCA also highlighted innovative collaborations at several sites:
n Researchers at the University of Kansas Medical Center and Children’s
n Stormont-Vail HealthCare in Topeka has begun several new trials conceived by researchers at the University of Kansas Medical Center, fulfilling the MCA’s mission of providing access to trials to community cancer centers, thus allowing patients to receive cancer care close to home.
“These are just a few examples of how the Midwest Cancer Alliance is strong and getting stronger,” said MCA Medical Director Gary Doolittle, MD. “Our network of partners and collaborators also demonstrates strong regional support for The University of Kansas Cancer Center’s effort to attain National Cancer Institute designation. Our partners’ commitment and dedication was recognized in May, when a visiting group of directors from NCI-designated centers around the country said it was gratifying to see the MCA’s continued growth.”
“Regional health care and research institutions recognize the tremendous burden cancer places on our families and the tremendous opportunities we have before us,” added former Kansas Lt. Gov. Gary Sherrer, the MCA’s founding chair. “There is no greater challenge we can meet than by bringing the latest and most cutting-edge clinical trials and treatments to people in this region. I know we can achieve this through the collaboration of the institutions in the Midwest Cancer Alliance.”
Midwest Cancer Alliance 2010 members:
MCA Partners Advisory Board
Stormont-Vail HealthCare -- Maynard Oliverius, President/CEO
The University of
Truman Medical Centers -- John W. Bluford III, President/CEO
Research Institution Members:
Roy Jensen, MD
Director, The University of
Barbara Atkinson, MD
Jeffrey S. Vitter, PhD
University of Kansas Provost and Executive Vice Chancellor
Stowers Institute for Medical Research – David M. Chao, PhD, President
Board Chair (Civic Leader) – Gary Sherrer
Kansas Governor’s Office – Lt. Gov. Troy Findley (ex-officio)
MCA Clinical Trials Network
St. Francis Health Center
Saint Luke’s Health System
The University of
Truman Medical Centers
Via Christi Hospital in PittsburgEmail this article | View All School of Medicine News | School of Medicine web site